Theramyt Novobiologics
Total Raised
$4.5MDeal Terms
1Theramyt Novobiologics Funding, Theramyt Novobiologics Valuation & Theramyt Novobiologics Revenue
1 Fundings
Theramyt Novobiologics's latest funding round was a Series A for $4.5M on October 11, 2013.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/11/2013 | Series A | $4.5M | 1 |
Date | 10/11/2013 |
|---|---|
Round | Series A |
Amount | $4.5M |
Investors | |
Valuation | |
Revenue | |
Sources | 1 |
Theramyt Novobiologics Deal Terms
1 Deal Term
Theramyt Novobiologics's deal structure is available for 1 funding round, including their Series A from October 11, 2013.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.